Evidence map›Paper›PMID 37027896›Full record

ArticleRespiratory medicine and research2023

Recovery after admission with COVID-19 pneumonia - A follow-up study.

Simone van der Sar-van der Brugge, Antine Flikweert, Arthur du Mee, Kim Gense, Sander Talman, Merijn Kant, Ingrid De Backer

Open access · greenAbstract read
In one paragraph

Article in Respiratory medicine and research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Observational
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Simone van der Sar-van der BruggeAmphia Hospital, Department of Pulmonary Medicine, Postbus 90158, 4800 RK Breda, the Netherlands. Electronic address: svandersar@amphia.nl.
Antine FlikweertAmphia Hospital, Department of Pulmonary Medicine, Postbus 90158, 4800 RK Breda, the Netherlands.
Arthur du MeeAmphia Hospital, Department of Radiology, Postbus 90158, 4800 RK Breda, the Netherlands.
Kim GenseCanisius Wilhelmina Hospital, Department of Pulmonary Medicine, Postbus 9015, 500GS Nijmegen, the Netherlands.
Sander TalmanAmphia Hospital, Department of Pulmonary Medicine, Postbus 90158, 4800 RK Breda, the Netherlands.
Merijn KantAmphia Hospital, Department of Pulmonary Medicine, Postbus 90158, 4800 RK Breda, the Netherlands; Amphia Hospital, Department of Intensive Care Medicine, Postbus 90158, 4800 RK Breda, the Netherlands.
Ingrid De BackerAmphia Hospital, Department of Pulmonary Medicine, Postbus 90158, 4800 RK Breda, the Netherlands.
Amphia Ziekenhuis · NLCanisius-Wilhelmina Ziekenhuis · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionWe performed this study to describe clinical, radiological and pulmonary function outcomes of patients with COVID-19 pneumonia 1 year after discharge from hospital.

methodsThis is a prospective longitudinal study on patients admitted with COVID-19 pneumonia in March and April 2020. 162 patients were classified as moderate, severe or critical. Symptoms and pulmonary function were assessed at 3 months and 1 year after discharge. Chest CT scans were made during hospital admission, at 3 months and, in case of persistent radiological abnormalities, after 1 year.

results54% of patients reported full recovery of their pre-illness fitness after 1 year. 53% still reported exertional dyspnoea, independent of illness severity. DLCOc < 80% after 1 year was found in 74% of critical, 50% of severe and 38% of moderate cases. For KCOc<80%, no between-group difference was found. Restriction (TLC<80%) was found in 28% of critical, 5% of severe, and 13% of moderate cases. At baseline, chest CT score was significantly higher for the critical illness group, but after 1 year, there was no significant difference. Most resolution of abnormalities occurred before 3 months. A high prevalence of fibrotic lesions (24%) and subpleural banding (27%) was found. CONCLUSION/CLINICAL IMPLICATION: A large proportion of patients experience consequences of COVID-19 pneumonia one year after discharge, irrespective of initial disease severity. Follow-up of patients admitted with COVID-19 is therefore warranted. An evaluation of symptoms, pulmonary function and radiology three months after discharge can discriminate between patients with early complete recovery and those with persistent abnormalities.

Indexed as

COVID-19Follow-Up StudiesHumansLongitudinal StudiesProspective StudiesSARS-CoV-2COVID-19DyspnoeaPneumoniaPulmonary functionRadiology

Identifiers

PMID37027896
PMCPMC9902280
OpenAlexW4319444549

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.